IL10 and COVID-19: Further studies are needed to elucidate whether exogenous administration of IL-10 or molecules able to act as adjuvant for the activation of anti-inflammatory IL-10 signaling may be beneficial for ameliorating COVID-19 and post-COVID-19 symptoms.